Capecitabine vs Imatinib
Compare Capecitabine and Imatinib side by side: what they treat, drug class, cost and FDA label information.
| Capecitabine | Imatinib | |
|---|---|---|
| Drug class | Nucleoside Metabolic Inhibitor | Kinase Inhibitor |
| Used to treat | Breast neoplasms, Colorectal neoplasms | Blast crisis, Dermatofibrosarcoma, Gastrointestinal neoplasms, Hypereosinophilic syndrome, Leukemia, myeloid, accelerated phase, Lymphoid leukemia, Myelodysplastic-myeloproliferative diseases, Myeloid leukemia, Systemic mastocytosis |
| Generic price | From $0.36 each, about $10.85 for 30 (150 mg tablet) | From $0.62 each, about $18.73 for 30 (100 mg tablet) |
| Brand price | No brand price listed | No brand price listed |
| Generic savings | Not listed | Not listed |